NGFN, or the National Genome Research Network, is a prominent biomedicine research program that was operational from 2001 to 2013, supported by Germany's Federal Ministry of Education and Research (BMBF) with over 600 million euros in funding. This program focused on advancing medical genome research to understand complex molecular interactions vital to human health. It successfully produced over 5,200 publications, establishing a strong presence in the global scientific community.

NGFN encompasses various initiatives, including NGFN-Plus, which concentrates on analyzing molecular relationships and combating significant health issues, and NGFN-Transfer, which bridges scientific discoveries with practical medical applications. The program has fostered innovative diagnostic and therapeutic approaches, identifying numerous biomarkers and contributing to the development of personalized medicine.

Through collaborations across multiple countries and the establishment of technology platforms and biobanks, NGFN has significantly enhanced Germany's research landscape. Its legacy continues to benefit patients today while paving the way for future advancements in genomics and personalized healthcare.